STOCK TITAN

Teleflex (NYSE: TFX) counsel awarded stock, small tax share withholding

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Teleflex executive Daniel V. Logue, CVP, General Counsel & Secretary, reported a mix of equity grants and a tax-related share withholding. On March 3, 2026, he received a stock option award for 21,510 shares at $0.00 per share and two common stock awards of 3,262 and 6,591 shares under the Teleflex Incorporated 2023 Stock Incentive Plan. The footnotes state these restricted stock unit and option awards vest in stages between March 3, 2027 and March 3, 2030, subject to his continuous service.

On March 4, 2026, 131 common shares were disposed of at $119.18 per share to satisfy tax liabilities upon vesting of a restricted stock unit award, described as shares withheld rather than an open-market sale. After these transactions, he directly holds 24,652.888 common shares, and an additional 305.683 shares are held indirectly by a 401(k) trustee.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Logue Daniel V.

(Last) (First) (Middle)
550 E. SWEDESFORD ROAD
SUITE 400

(Street)
WAYNE PA 19087

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TELEFLEX INC [ TFX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CVP, General Counsel & Secty
3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/03/2026 A(1) 3,262 A $0 18,192.888 D
Common Stock 03/03/2026 A(2) 6,591 A $0 24,783.888 D
Common Stock 03/04/2026 F(3) 131 D $119.18 24,652.888 D
Common Stock 305.683 I By 401(k) Trustee
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option / (Right to Buy) $122.19 03/03/2026 A 21,510 (4) 03/03/2036 Common Stock 21,510 $0 21,510 D
Explanation of Responses:
1. Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. 25% of the shares underlying the award will vest on each of 3/3/27, 3/3/28, 3/3/29 and 3/3/30, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
2. Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. 50% of the shares underlying the award will vest on each of 3/3/2027 and 9/3/2027, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
3. Shares withheld to satisfy tax liability upon vesting of restricted stock unit award.
4. One third of the shares underlying the stock option will vest on each of 3/3/2027, 3/3/2028 and 3/3/2029, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
Remarks:
Daniel V. Logue 03/05/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Teleflex (TFX) report for Daniel V. Logue?

Teleflex reported that Daniel V. Logue received stock option and restricted stock unit awards, plus a small share withholding for taxes. He was granted 21,510 options and 9,853 common shares, and 131 shares were withheld at $119.18 to cover tax obligations on vested units.

How many Teleflex (TFX) stock options were granted to Daniel V. Logue in this Form 4?

Daniel V. Logue was granted a stock option covering 21,510 shares of Teleflex common stock at an exercise price of $0.00. According to the footnotes, one third of these option shares vest on each of March 3, 2027, March 3, 2028, and March 3, 2029, contingent on continued service.

What restricted stock unit awards did Daniel V. Logue receive from Teleflex (TFX)?

He received restricted stock unit awards totaling 9,853 Teleflex common shares, split into 3,262 and 6,591-share grants. Footnotes explain vesting schedules: one award vests 25% annually from March 3, 2027 to March 3, 2030, and another vests 50% on March 3, 2027 and 50% on September 3, 2027.

Why were 131 Teleflex (TFX) shares disposed of in Daniel V. Logue’s Form 4?

The 131 Teleflex shares were withheld to satisfy tax liabilities arising when a restricted stock unit award vested. The Form 4 labels this as a tax-withholding disposition at $119.18 per share, rather than an open-market sale initiated for investment or portfolio reasons.

What is Daniel V. Logue’s Teleflex (TFX) share ownership after these transactions?

After the reported grants and tax withholding, Daniel V. Logue directly owns 24,652.888 Teleflex common shares. Additionally, 305.683 shares are held indirectly in a 401(k) plan, with the Form 4 identifying the ownership nature as “By 401(k) Trustee” for that indirect position.

Over what period do Daniel V. Logue’s new Teleflex (TFX) awards vest?

The new equity awards vest over several years starting in 2027. Restricted stock units vest in installments between March 3, 2027 and March 3, 2030, while the stock options vest in three equal annual tranches on March 3, 2027, March 3, 2028, and March 3, 2029, subject to continued service.
Teleflex Inc

NYSE:TFX

TFX Rankings

TFX Latest News

TFX Latest SEC Filings

TFX Stock Data

5.20B
43.97M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
WAYNE